Works by Neven, Patrick
Results: 135
A Real-Life Analysis of Reproductive Outcome after Fertility Preservation in Female Cancer Patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Staging with Unilateral Salpingo-Oophorectomy and Expert Pathological Review Result in No Recurrences in a Series of 81 Intestinal-Type Mucinous Borderline Ovarian Tumors.
- Published in:
- Gynecologic & Obstetric Investigation, 2018, v. 83, n. 1, p. 65, doi. 10.1159/000478929
- By:
- Publication type:
- Article
CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 6, p. 441, doi. 10.1093/jnci/djs125
- By:
- Publication type:
- Article
Breast Cancer Incidence in the Randomized PEARL Trial of Lasofoxifene in Postmenopausal Osteoporotic Women.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 22, p. 1706, doi. 10.1093/jnci/djq415
- By:
- Publication type:
- Article
Discrimination Between Benign and Malignant Adnexal Masses by Specialist Ultrasound Examination Versus Serum CA-125.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 22, p. 1706, doi. 10.1093/jnci/djm199
- By:
- Publication type:
- Article
Intraperitoneal Chemotherapy in Patients with Advanced Ovarian Cancer: The Con View.
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 410, doi. 10.1634/theoncologist.2007-0224
- By:
- Publication type:
- Article
Correction to: Unexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Unexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 11, p. 1071, doi. 10.1007/s40261-018-0696-3
- By:
- Publication type:
- Article
Machine Learning Algorithm to Estimate Distant Breast Cancer Recurrence at the Population Level with Administrative Data.
- Published in:
- Clinical Epidemiology, 2023, v. 15, p. 559, doi. 10.2147/CLEP.S400071
- By:
- Publication type:
- Article
Association between CYP2D6 polymorphisms and breast cancer outcomes.
- Published in:
- 2010
- By:
- Publication type:
- commentary
Association Between CYP2D6 Polymorphisms and Breast Cancer Outcomes.
- Published in:
- 2010
- By:
- Publication type:
- Letter
The footprint of the ageing stroma in older patients with breast cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Immune profiles of elderly breast cancer patients are altered by chemotherapy and relate to clinical frailty.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR<sup>+</sup>, HER2<sup>-</sup> breast cancer that had progressed during or after prior endocrine therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Extending the Developmental Origins of Health and Disease theory: does paternal diet contribute to breast cancer risk in daughters?
- Published in:
- Breast Cancer Research, 2016, v. 18, p. 1, doi. 10.1186/s13058-016-0760-y
- By:
- Publication type:
- Article
Author Correction: FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00331-8
- By:
- Publication type:
- Article
Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer.
- Published in:
- NPJ Genomic Medicine, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41525-022-00300-5
- By:
- Publication type:
- Article
Additional Value of PET-CT in Staging of Clinical Stage IIB and III Breast Cancer SEGAERT ET AL Additional Value of PET-CT in Staging of Clinical Stage IIB and III Breast Cancer.
- Published in:
- Breast Journal, 2010, v. 16, n. 6, p. 617, doi. 10.1111/j.1524-4741.2010.00987.x
- By:
- Publication type:
- Article
Aromatase Inhibitors in Premenopausal Women: The Need for Proper Contraceptive Counseling.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Cognitions and physical impairments in relation to upper limb function in women with pain and myofascial dysfunctions in the late stage after breast cancer surgery: an exploratory cross-sectional study.
- Published in:
- Disability & Rehabilitation, 2022, v. 44, n. 18, p. 5212, doi. 10.1080/09638288.2021.1931482
- By:
- Publication type:
- Article
Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
- Published in:
- 2020
- By:
- Publication type:
- corrected article
The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The costs of breast cancer prior to and following diagnosis.
- Published in:
- European Journal of Health Economics, 2011, v. 12, n. 4, p. 311, doi. 10.1007/s10198-010-0237-3
- By:
- Publication type:
- Article
Elevated CA 15.3 in Newly Diagnosed Breast Cancer: A Retrospective Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Quality-Adjusted Survival with Ribociclib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women with HR±HER2- Advanced Breast Cancer in the MONALEESA-3 Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Associations Between Patient and Anthropometric Characteristics and Aromatase Inhibitor Discontinuation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Disease management patterns for postmenopausal women in Europe with hormone-receptor-positive, human epidermal growth factor receptor-2 negative advanced breast cancer.
- Published in:
- Current Medical Research & Opinion, 2014, v. 30, n. 6, p. 1007, doi. 10.1185/03007995.2014.887002
- By:
- Publication type:
- Article
Health-related quality of life and disease symptoms in postmenopausal women with HR(+), HER2(-) advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Effective Inhibition of Aromatase Inhibitor-associated Bone Loss by Zoledronic Acid in Postmenopausal Women With Early Breast Cancer Receiving Adjuvant Letrozole.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 5, p. 1001, doi. 10.1002/cncr.23259
- By:
- Publication type:
- Article
Significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen-treated women.
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 2, p. 431
- By:
- Publication type:
- Article
Dissecting the immune infiltrate of primary luminal B‐like breast carcinomas in relation to age.
- Published in:
- Journal of Pathology, 2024, v. 264, n. 3, p. 344, doi. 10.1002/path.6354
- By:
- Publication type:
- Article
Bilateral Mammary Tuberculosis Associated with a Borderline Ovarian Tumor.
- Published in:
- Breast Care, 2008, v. 3, n. 3, p. 200, doi. 10.1159/000136105
- By:
- Publication type:
- Article
Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer.
- Published in:
- BMC Medicine, 2015, v. 13, n. 1, p. 177, doi. 10.1186/s12916-015-0416-2
- By:
- Publication type:
- Article
Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for ERBB2-Positive Breast Cancer: A Secondary Analysis of the SOLD Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 8, p. e2429772, doi. 10.1001/jamanetworkopen.2024.29772
- By:
- Publication type:
- Article
Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors: existing and emerging differences.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 4, p. 1, doi. 10.1093/jncics/pkad045
- By:
- Publication type:
- Article
Serum methylmalonic acid concentrations at breast cancer diagnosis significantly correlate with clinical frailty.
- Published in:
- GeroScience, 2024, v. 46, n. 2, p. 1489, doi. 10.1007/s11357-023-00908-0
- By:
- Publication type:
- Article
Solving current dilemmas in the adjuvant endocrine treatment of pre- and perimenopausal women with an estrogen receptor positive breast cancer.
- Published in:
- European Journal of Gynaecological Oncology, 2021, v. 42, n. 4, p. 621, doi. 10.31083/j.ejgo4204097
- By:
- Publication type:
- Article
The added value of geriatric assessment in evaluating a patient's Health‐Related Quality‐of‐Life: A study in ≥70‐year‐old early‐stage invasive breast cancer patients.
- Published in:
- European Journal of Cancer Care, 2020, v. 29, n. 5, p. 1, doi. 10.1111/ecc.13278
- By:
- Publication type:
- Article
Age‐dependent brain volume and neuropsychological changes after chemotherapy in breast cancer patients.
- Published in:
- Human Brain Mapping, 2019, v. 40, n. 17, p. 4994, doi. 10.1002/hbm.24753
- By:
- Publication type:
- Article
Clinical behavior of recurrent hormone receptor–positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1‐98 clinical trial.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 5, p. 700, doi. 10.1002/cncr.33318
- By:
- Publication type:
- Article
Effects of a mindfulness-based intervention on cancer-related cognitive impairment: Results of a randomized controlled functional magnetic resonance imaging pilot study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 10, p. 1908, doi. 10.1002/cncr.28010
- By:
- Publication type:
- Article
Patterns of resource utilization and cost for postmenopausal women with hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer in Europe.
- Published in:
- 2015
- By:
- Publication type:
- journal article
RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish Observational Cohort Study.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 8, p. 998, doi. 10.1093/jnci/djad089
- By:
- Publication type:
- Article
Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A Systematic Review of Estimating Breast Cancer Recurrence at the Population Level With Administrative Data.
- Published in:
- 2020
- By:
- Publication type:
- journal article